Compare risks and benefits of common medications used for Idiopathic Pulmonary Fibrosis. Find the most popular drugs, view ratings and user reviews.

Currently, two drugs are FDA-approved for treatment of idiopathic pulmonary fibrosis (IPF), which is the most common form of PF. These include nintedanib (Ofev®) and pirfenidone (Esbriet®).

Nintedanib is an oral medication approved for the treatment of idiopathic pulmonary fibrosis, systemic sclerosis associated interstitial lung disease, and chronic interstitial lung diseases in …

Compare risks and benefits of common medications used for Pulmonary Fibrosis. Find the most popular drugs, view ratings and user reviews.

Idiopathic pulmonary fibrosis (IPF; also called cryptogenic fibrosing alveolitis) is specific form of chronic, progressive, fibrosing interstitial pneumonia of unknown cause, occurring in adults …

Jul 16, 2020 · Medical treatment options include two approved antifibrotic (anti-scarring) drugs. Pirfenidone is an antifibrotic drug that can slow the progression of lung tissue damage. It has...

In this review article, we aim to summarize the existing and novel pharmacotherapies for the treatment of IPF (excluding treatments for acute exacerbations), focusing on the current …

Currently, there are two antifibrotic drugs that have been approved for the treatment of IPF - pirfenidone and nintedanib 5, 6. However, both of these drugs have modest benefits and only …

Idiopathic pulmonary fibrosis (IPF) remains a fatal and incurable disease despite the use of approved antifibrotic drugs. Development of novel antifibrotics drugs has consistently …

While there is no cure for IPF, there are medications that can help with symptoms and slow progression of the disease. Treatment of IPF is important because lung function and …